Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Van Drie

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Molecular Graphics & Modelling|February 23, 2002
Enhancement of binary QSAR analysis by a GA-based variable selection methodHua Gao, Michael S Lajiness, John Van Drie
Cell Cycle (Georgetown, Tex.)|December 11, 2020
Clinical stage molecule PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2Neil D Theise, Anthony R Arment, Dimple Chakravarty, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Inhibitors of hepatitis C virus NS3.4A protease. Effect of P4 capping groups on inhibitory potency and pharmacokineticsRobert B Perni, Gurudatt Chandorkar, Kevin M Cottrell, et al.
Journal of Chemical Information and Modeling|March 28, 2015
FOCUS--Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal ChemistsNikolaus Stiefl, Peter Gedeck, Donovan Chin, et al.
Plos One|April 25, 2015
A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1Matthew C Clifton, David M Dranow, Alison Leed, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Molecular Graphics & Modelling|February 23, 2002
Enhancement of binary QSAR analysis by a GA-based variable selection methodHua Gao, Michael S Lajiness, John Van Drie
Cell Cycle (Georgetown, Tex.)|December 11, 2020
Clinical stage molecule PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2Neil D Theise, Anthony R Arment, Dimple Chakravarty, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Inhibitors of hepatitis C virus NS3.4A protease. Effect of P4 capping groups on inhibitory potency and pharmacokineticsRobert B Perni, Gurudatt Chandorkar, Kevin M Cottrell, et al.
Journal of Chemical Information and Modeling|March 28, 2015
FOCUS--Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal ChemistsNikolaus Stiefl, Peter Gedeck, Donovan Chin, et al.
Plos One|April 25, 2015
A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1Matthew C Clifton, David M Dranow, Alison Leed, et al.
Pageof 1